Ledger.Open graph →
SEC Form D · Amendment · filed March 1, 2023

SightStream Biotherapeutics, Inc

Offering
$3.5M
Sold
$2.9M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
MEDFIELD, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

David Neafus · Medfield, MAExecReza Dana · Medfield, MADirectorJiagang Zhao · Medfield, MADirectorJason Werner · Medfield, MAExec · DirectorGeorge Mulhern · Boise, IDExecNick Efstratis · Boise, IDExec · DirectorRick Farnell · Boise, IDDirectorBrad Osborne · Brentwood, TNDirectorRobert J. Short · Polson, MTDirectorChris Popp · New York, NYExecMike Tobin · New York, NYDirectorJean-Bastien Auger · New York, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗